TY - JOUR
T1 - Inhibiting Analyte Theft in Surface-Enhanced Raman Spectroscopy Substrates: Subnanomolar Quantitative Drug Detection
AU - Nijs, Bart de
AU - Carnegie, Cloudy
AU - Szabó, István
AU - Grys, David-Benjamin
AU - Chikkaraddy, Rohit
AU - Kamp, Marlous
AU - Barrow, Steven J.
AU - Readman, Charlie A.
AU - Kleemann, Marie-Elena
AU - Scherman, Oren A.
AU - Rosta, Edina
AU - Baumberg, Jeremy J.
PY - 2019/9
Y1 - 2019/9
N2 - Quantitative applications of surface-enhanced Raman spectroscopy (SERS) often rely on surface partition layers grafted to SERS substrates to collect and trap-solvated analytes that would not otherwise adsorb onto metals. Such binding layers drastically broaden the scope of analytes that can be probed. However, excess binding sites introduced by this partition layer also trap analytes outside the plasmonic “hotspots”. We show that by eliminating these binding sites, limits of detection (LODs) can effectively be lowered by more than an order of magnitude. We highlight the effectiveness of this approach by demonstrating quantitative detection of controlled drugs down to subnanomolar concentrations in aqueous media. Such LODs are low enough to screen, for example, urine at clinically relevant levels. These findings provide unique insights into the binding behavior of analytes, which are essential when designing high-performance SERS substrates.
AB - Quantitative applications of surface-enhanced Raman spectroscopy (SERS) often rely on surface partition layers grafted to SERS substrates to collect and trap-solvated analytes that would not otherwise adsorb onto metals. Such binding layers drastically broaden the scope of analytes that can be probed. However, excess binding sites introduced by this partition layer also trap analytes outside the plasmonic “hotspots”. We show that by eliminating these binding sites, limits of detection (LODs) can effectively be lowered by more than an order of magnitude. We highlight the effectiveness of this approach by demonstrating quantitative detection of controlled drugs down to subnanomolar concentrations in aqueous media. Such LODs are low enough to screen, for example, urine at clinically relevant levels. These findings provide unique insights into the binding behavior of analytes, which are essential when designing high-performance SERS substrates.
U2 - 10.1021/acssensors.9b01484
DO - 10.1021/acssensors.9b01484
M3 - Article
SN - 1424-8220
VL - 4
SP - 2988
EP - 2996
JO - Sensors
JF - Sensors
IS - 11
ER -